ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vestbo, J
Right arrow Articles by Rasmussen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vestbo, J
Right arrow Articles by Rasmussen, F.
Eur Respir J 1989; 2: 710-715
Copyright © ERS Journals Ltd 1989


Original Articles

Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease

J Vestbo and FV Rasmussen

The predictive value of cough, mucus hypersecretion, breathlessness, chronic bronchitis and forced expiratory volume in one second (FEV1) for hospitalization and medication were examined in a random population sample of 876 men, 46-69 yrs of age. All of the men were examined in 1974 with interview and lung function tests. Information on hospitalization in the period 1977-1986 was obtained from the Danish National Patient Register, and information on drug usage was obtained from 567 men in a questionnaire survey ultimo 1985. FEV1 was a strong predictor of both hospitalization and medication. Respiratory symptoms were good predictors of hospitalization due to either respiratory disease in general (odds ratios 2.56-3.29), or chronic obstructive pulmonary disease (COPD), (odds ratios 4.16-5.75). They contained predictive values in addition to that provided by FEV1. Respiratory symptoms were good predictors of medication for airway obstruction, relative risks 3.56-4.70, and/or airway disease in general, relative risks 2.67-4.69. After controlling for FEV1, cough was still significantly associated with treatment for airway disease in general and both cough, mucus hypersecretion and chronic bronchitis were significantly associated with treatment for airway obstruction. We conclude that apart from FEV1, respiratory symptoms are independent predictors of hospitalization and medication due to respiratory disease.


This article has been cited by other articles:


Home page
ChestHome page
R. McGhan, T. Radcliff, R. Fish, E. R. Sutherland, C. Welsh, and B. Make
Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD
Chest, December 1, 2007; 132(6): 1748 - 1755.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J R Hurst and J A Wedzicha
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation
Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
J Vestbo
Chronic bronchitis: should it worry us?
Chronic Respiratory Disease, July 1, 2004; 1(3): 173 - 176.
[Abstract] [PDF]


Home page
ChestHome page
S.-A. Jansson, F. Andersson, S. Borg, A. Ericsson, E. Jonsson, and B. Lundback
Costs of COPD in Sweden According to Disease Severity
Chest, December 1, 2002; 122(6): 1994 - 2002.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T.M.L. Eagan, P.S. Bakke, G.E. Eide, and A. Gulsvik
Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study
Eur. Respir. J., April 1, 2002; 19(4): 599 - 605.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the European Respiratory Society.